Atlas Trials

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines

Clinical trial NCT01391299 · COMPLETED

Trial details

NCT number
NCT01391299
Sponsor
Allergan
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Facial RhytidesGlabellar Frown Lines
Start date
2011-06-01
Primary completion
2011-10-18
Enrollment
175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.